# Camden National Corp: financial statements, quarterly

CAC · Nasdaq · CIK 750686 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cac.md) · [Financials](/companies/cac/financials.md) · [Filings](/companies/cac/filings.md) · [Insiders](/companies/cac/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cac/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [8.5](/filings/0000750686-24-000262.md) | [8.8 d](/filings/0000750686-26-000010.md) | [8.3](/filings/0000750686-25-000214.md) | [8.9](/filings/0000750686-25-000282.md) | [9.1](/filings/0000750686-25-000306.md) | [9.4 d](/filings/0000750686-26-000010.md) | [9.5](/filings/0000750686-26-000026.md) | [10.4](/filings/0000750686-26-000062.md) | [10.6](/filings/0000750686-25-000306.md) | [11.3 d](/filings/0000750686-26-000010.md) | [9.7](/filings/0000750686-26-000026.md) | [11.2](/filings/0000750686-26-000062.md) |
| Interest expense | $m | [25.1](/filings/0000750686-24-000262.md) | [27.1 d](/filings/0000750686-24-000025.md) | [28.9](/filings/0000750686-24-000186.md) | [30.0](/filings/0000750686-24-000238.md) | [30.1](/filings/0000750686-24-000262.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [2.2](/filings/0000750686-24-000262.md) | [1.8 d](/filings/0000750686-26-000010.md) | [3.1](/filings/0000750686-25-000214.md) | [2.9](/filings/0000750686-25-000282.md) | [2.8](/filings/0000750686-25-000306.md) | [3.7 d](/filings/0000750686-26-000010.md) | [(1.2)](/filings/0000750686-26-000026.md) | [3.7](/filings/0000750686-26-000062.md) | [5.3](/filings/0000750686-25-000306.md) | [5.7 d](/filings/0000750686-26-000010.md) | [6.2](/filings/0000750686-26-000026.md) | [6.3](/filings/0000750686-26-000062.md) |
| Net income | $m | [9.8](/filings/0000750686-24-000262.md) | [8.5 d](/filings/0000750686-26-000010.md) | [13.3](/filings/0000750686-25-000214.md) | [12.0](/filings/0000750686-25-000282.md) | [13.1](/filings/0000750686-25-000306.md) | [14.7 d](/filings/0000750686-26-000010.md) | [7.3](/filings/0000750686-26-000026.md) | [14.1](/filings/0000750686-26-000062.md) | [21.2](/filings/0000750686-25-000306.md) | [22.6 d](/filings/0000750686-26-000010.md) | [21.9](/filings/0000750686-26-000026.md) | [23.0](/filings/0000750686-26-000062.md) |
| Diluted EPS | $ per share | [0.67](/filings/0000750686-24-000262.md) | not reported | [0.91](/filings/0000750686-25-000214.md) | [0.81](/filings/0000750686-25-000282.md) | [0.90](/filings/0000750686-25-000306.md) | not reported | [0.43](/filings/0000750686-26-000026.md) | [0.83](/filings/0000750686-26-000062.md) | [1.25](/filings/0000750686-25-000306.md) | not reported | [1.29](/filings/0000750686-26-000026.md) | [1.35](/filings/0000750686-26-000062.md) |
| Basic EPS | $ per share | [0.67](/filings/0000750686-24-000262.md) | not reported | [0.91](/filings/0000750686-25-000214.md) | [0.82](/filings/0000750686-25-000282.md) | [0.90](/filings/0000750686-25-000306.md) | not reported | [0.43](/filings/0000750686-26-000026.md) | [0.84](/filings/0000750686-26-000062.md) | [1.25](/filings/0000750686-25-000306.md) | not reported | [1.29](/filings/0000750686-26-000026.md) | [1.36](/filings/0000750686-26-000062.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [5,780](/filings/0000750686-23-000285.md) | [5,715](/filings/0000750686-25-000044.md) | [5,795](/filings/0000750686-24-000186.md) | [5,724](/filings/0000750686-24-000238.md) | [5,745](/filings/0000750686-24-000262.md) | [5,805](/filings/0000750686-26-000010.md) | [6,965](/filings/0000750686-25-000214.md) | [6,920](/filings/0000750686-25-000282.md) | [6,982](/filings/0000750686-25-000306.md) | [6,975](/filings/0000750686-26-000062.md) | [6,962](/filings/0000750686-26-000026.md) | [6,951](/filings/0000750686-26-000062.md) |
| Total liabilities | $m | [5,316](/filings/0000750686-23-000285.md) | [5,219](/filings/0000750686-25-000044.md) | [5,293](/filings/0000750686-24-000186.md) | [5,216](/filings/0000750686-24-000238.md) | [5,215](/filings/0000750686-24-000262.md) | [5,274](/filings/0000750686-26-000010.md) | [6,325](/filings/0000750686-25-000214.md) | [6,268](/filings/0000750686-25-000282.md) | [6,305](/filings/0000750686-25-000306.md) | [6,278](/filings/0000750686-26-000062.md) | [6,252](/filings/0000750686-26-000026.md) | [6,225](/filings/0000750686-26-000062.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | [470](/filings/0000750686-23-000285.md) | [486](/filings/0000750686-25-000044.md) | [601](/filings/0000750686-24-000186.md) | [553](/filings/0000750686-24-000238.md) | [516](/filings/0000750686-24-000262.md) | [501](/filings/0000750686-26-000010.md) | [567](/filings/0000750686-25-000214.md) | [599](/filings/0000750686-25-000282.md) | [748](/filings/0000750686-25-000306.md) | [582](/filings/0000750686-26-000062.md) | [513](/filings/0000750686-26-000026.md) | [508](/filings/0000750686-26-000062.md) |
| Shareholders' equity | $m | [463](/filings/0000750686-24-000262.md) | [495](/filings/0000750686-26-000010.md) | [502](/filings/0000750686-25-000282.md) | [508](/filings/0000750686-25-000306.md) | [530](/filings/0000750686-25-000306.md) | [531](/filings/0000750686-26-000062.md) | [640](/filings/0000750686-26-000062.md) | [652](/filings/0000750686-26-000062.md) | [676](/filings/0000750686-25-000306.md) | [697](/filings/0000750686-26-000062.md) | [710](/filings/0000750686-26-000062.md) | [726](/filings/0000750686-26-000062.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [47.2 d](/filings/0000750686-24-000262.md) | [(11.3) d](/filings/0000750686-26-000010.md) | [17.8](/filings/0000750686-25-000214.md) | [14.5 d](/filings/0000750686-25-000282.md) | [(14.5) d](/filings/0000750686-25-000306.md) | [43.2 d](/filings/0000750686-26-000010.md) | [1.0](/filings/0000750686-26-000026.md) | [6.0 d](/filings/0000750686-26-000062.md) | [36.1 d](/filings/0000750686-25-000306.md) | [20.8 d](/filings/0000750686-26-000010.md) | [20.0](/filings/0000750686-26-000026.md) | [31.2 d](/filings/0000750686-26-000062.md) |
| Capital expenditure | $m | [0.7 d](/filings/0000750686-24-000262.md) | [0.9 d](/filings/0000750686-26-000010.md) | [0.5](/filings/0000750686-25-000214.md) | [1.3 d](/filings/0000750686-25-000282.md) | [1.7 d](/filings/0000750686-25-000306.md) | [2.0 d](/filings/0000750686-26-000010.md) | [1.8](/filings/0000750686-26-000026.md) | [1.5 d](/filings/0000750686-26-000062.md) | [0.7 d](/filings/0000750686-25-000306.md) | [1.8 d](/filings/0000750686-26-000010.md) | [1.8](/filings/0000750686-26-000026.md) | [1.3 d](/filings/0000750686-26-000062.md) |
| Dividends paid | $m | [6.1 d](/filings/0000750686-24-000262.md) | [6.1 d](/filings/0000750686-26-000010.md) | [6.1](/filings/0000750686-25-000214.md) | [6.1 d](/filings/0000750686-25-000282.md) | [6.1 d](/filings/0000750686-25-000306.md) | [6.1 d](/filings/0000750686-26-000010.md) | [7.1](/filings/0000750686-26-000026.md) | [7.1 d](/filings/0000750686-26-000062.md) | [7.1 d](/filings/0000750686-25-000306.md) | [7.1 d](/filings/0000750686-26-000010.md) | [7.1](/filings/0000750686-26-000026.md) | [7.1 d](/filings/0000750686-26-000062.md) |
| Share repurchases | $m | [0.0 d](/filings/0000750686-24-000262.md) | [0.0 d](/filings/0000750686-26-000010.md) | not reported | not reported | [0.0 d](/filings/0000750686-25-000306.md) | [(0.0) d](/filings/0000750686-26-000010.md) | [0.0](/filings/0000750686-26-000026.md) | [0.0 d](/filings/0000750686-26-000062.md) | [0.0 d](/filings/0000750686-25-000306.md) | [0.0 d](/filings/0000750686-26-000010.md) | [1.5](/filings/0000750686-26-000026.md) | [2.5](/filings/0000750686-26-000062.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends, us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [14.7](/filings/0000750686-23-000285.md) | [14.6](/filings/0000750686-24-000186.md) | [14.6](/filings/0000750686-24-000238.md) | [14.6](/filings/0000750686-24-000262.md) | [14.6](/filings/0000750686-25-000214.md) | [14.6](/filings/0000750686-25-000282.md) | [14.6](/filings/0000750686-25-000306.md) | [16.9](/filings/0000750686-26-000026.md) | [17.0](/filings/0000750686-26-000062.md) | [17.0](/filings/0000750686-25-000306.md) | [17.0](/filings/0000750686-26-000026.md) | [17.0](/filings/0000750686-26-000062.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 16,897,049 at 2026-07-30, from the cover of the [10-Q filed 2026-08-06](/filings/0000750686-26-000062.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:23 ET. No prices; not investment advice.